Clinical Trial

Effect of Dexamethasone on Labour Induction in Term Pregnancies

Recruiting Early Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated August 7, 2025 (before its estimated September 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of the study is to assess the effect of dexamethasone on labour induction in term pregnancies. Primary outcome: The interval between initiation of induction and beginning of the active phase of labour. Secondary outcomes: * Duration of active phase of labour (starting with cervical dilatation of 4-5 cm up to full cervical dilatation). * Duration of second stage of labour * Mode of delivery. * Fetal outcome. Group A: Will receive one dose of IM dexamethasone sodium phosphate 8 mg (2 mL). Group B: Will receive vaginal misoprostol 25 μg tablets every 6 h, up to 4 tablets, for a maximum duration of 24 h. Group C: Will receive one dose of IM dexamethasone sodium phosphate 8mg (2mL) with the first dose of vaginal misoprostol 25 μg tablets that will be given every 6 h, up to 4 tablets, for a maximum duration of 24 h.
Trial Details
NCT Number NCT07109258
Lead Sponsor Cairo University
Conditions Labor Induction
Enrollment 150 participants
Start Date 2025-05-01
Primary Completion 2025-09-01 (estimated)
Study Completion 2025-09-15 (estimated)
Updated on ClinicalTrials.gov 2025-08-07